I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78%
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InDex Pharmaceuticals Holding AB
Net Income Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Net Income
-kr204.8m
CAGR 3-Years
-43%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Net Income
-kr353.1m
CAGR 3-Years
14%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Net Income
kr236.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Net Income
kr224.7m
CAGR 3-Years
24%
CAGR 5-Years
45%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Net Income
-kr180.8m
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Net Income
-kr27.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Net Income?
Net Income
-204.8m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Net Income amounts to -204.8m SEK.

What is InDex Pharmaceuticals Holding AB's Net Income growth rate?
Net Income CAGR 5Y
-23%

Over the last year, the Net Income growth was -921%. The average annual Net Income growth rates for InDex Pharmaceuticals Holding AB have been -43% over the past three years , -23% over the past five years .

Back to Top